Unknown

Dataset Information

0

First report of clinical response to Venetoclax in Early T-cell Precursor Acute Lymphoblastic Leukemia.

ABSTRACT:

SUBMITTER: Numan Y 

PROVIDER: S-EPMC6508880 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Changing of IKZF1 genotype during Philadelphia-negative precursor-B acute lymphoblastic leukemia progression: a short clinical report.
| S-EPMC4962816 | biostudies-literature
Unknown Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts.
| S-EPMC7370557 | biostudies-literature
Unknown Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.
| S-EPMC7967241 | biostudies-literature
Unknown Molecular response with blinatumomab in relapsed/refractory B-cell precursor acute lymphoblastic leukemia.
| S-EPMC6849936 | biostudies-literature
Unknown Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group.
| S-EPMC2265447 | biostudies-literature
Unknown Advances in B-cell Precursor Acute Lymphoblastic Leukemia Genomics.
| S-EPMC6746003 | biostudies-literature
Unknown Apoptosis pathway signature for prediction of treatment response and clinical outcome in childhood high risk B-Precursor acute lymphoblastic leukemia.
| S-EPMC4497450 | biostudies-literature
Unknown An early thymic precursor phenotype predicts outcome exclusively in HOXA-overexpressing adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
| S-EPMC5013941 | biostudies-literature
Unknown JAK2 aberrations in childhood B-cell precursor acute lymphoblastic leukemia.
| S-EPMC5685720 | biostudies-literature
Unknown Inhibiting casein kinase 2 sensitizes acute lymphoblastic leukemia cells to venetoclax via MCL1 degradation.
| S-EPMC8714730 | biostudies-literature